Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Big Year Ahead For New Vir CEO De Backer

2023 Could Be Transformational For US Biotech

Apr 11 2023

• By Kevin Grogan

Marianne De Backer — Marianne De Backer • Source: Vir

Related Content

GSK Ends Pact with Vir For New COVID Treatments

Feb 14 2023

Vir CEO George Scangos, Set To Retire, Reflects On A Long Career In Biotech

Jan 25 2023

Bayer Bids To Be A Winner In Cell & Gene Therapy

Dec 08 2020

Bayer Back In M&A Mode To Boost Pipeline

Aug 12 2020

Related Companies

Bayer AG

Vir Biotechnology, Inc.

Johnson & Johnson

Ridgeback Biotherapeutics LP

GSK plc

Gilead Sciences, Inc.

Vertex Pharmaceuticals Incorporated

Bristol Myers Squibb Company

Additional Topics

Leadership Business Strategies Clinical Trials Research & Development Infectious Diseases BioPharmaceutical

More from Leadership

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window